New breathing device aims to unclog lungs in bronchiectasis patients

NCT ID NCT07443124

Not yet recruiting Symptom relief Sponsor: Inogen Inc. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study will test the Simeox 200, a device designed to help clear mucus from the lungs, in 35 adults with bronchiectasis who produce a lot of phlegm. Participants will use the device twice daily for two weeks, and researchers will measure how much mucus is cleared, along with changes in lung function and symptoms. The goal is to see if the device is a practical and effective option for daily airway clearance at home.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Simeox 200 airway clearance device
What this could lead to: If successful, this device could offer a new way to help bronchiectasis patients clear mucus more easily at home, potentially reducing symptoms and improving daily life.
What could go wrong: This is a very small, early pilot study with only 35 people and no comparison group, so results may not apply broadly. The device may not work better than existing methods, and individual results can vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRONCHIECTASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bronchiectasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRONCHIECTASIS MUCUS; PLUG

Contacts and locations

Locations

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.